The Nomoramide the synthetic morphinomimetic drug project

Masters
Essay
Miscellaneous
Pages 9 (2259 words)
Download 0
The 'painfree' i.e. Nomoramide the synthetic morphinomimetic drug project appears to be a very ambitious project for Alpex Pharma AG. …

Introduction

The 'painfree' project appears a rather 'painful' project. Potential of the drug Nomoramide (painfree) appears to be immense, as specialists as well as General Physicians are fully convinced and have echoed their support for the drug, but the major drawback in managing the project has been a lack of sound understanding and respect for the views different departments within the company.

Project management as such is a set of principles, practices, and techniques applied to lead project team and control project schedule, cost, and performance risks in order to in delight the customers. But in case of 'painfree' the end result appears to be resulting in a rather painful experience for the company as well as for the customers. The project appears successful to the extent that it succeeded in convincing the General Physicians and specialists about the usefulness of the drug. It generated lot of curiosity about the company and the product, which can go a long way in generating marketing potential for the company in the long run.

It appears the company has been able to make good use of its contacts in the regulatory and licensing departments of the governments in different countries, yet it appears at loggerheads with authorities like BGA for continuously ignoring the genuine concerns of the people, which is resulting in restriction of the use of the drug to the post-operational pain, in Europe. In US though the company appears to have convinced in regulatory authorities regarding the drug’s unrestricted acceptance with specialists and GPs able to prescribe it for pain relief. ...
Download paper
Not exactly what you need?

Related papers

The Nomoramide the synthetic morphinomimetic drug project
The 'painfree' project appears a rather 'painful' project. Potential of the drug Nomoramide (painfree) appears to be immense, as specialists as well as General Physicians are fully convinced and have echoed their support for the drug, but the major drawback in managing the project has been a lack of sound understanding and respect for the views different departments within the company. …
Drug Plan
There would remain many essential aspects to consider, when addressing the issue of the drug problem nationwide, with prevention being one of the stronger factors. Prevention sought through the treatment of offenders and the increased awareness within the community bodies, of the real dangers that exist within the world of drug exposure. As it would come to the military, most notably the National…
Drug Treatment
The answer, may be found in the second article. Perhaps if the approach taken was a cultural one, society in general would look at addiction for what it isa disease. Historically speaking, addiction was never looked at through culture but merely as man's weakness for the drink. In the nineteenth century the temperance movement argued that alcohol inevitably provoked loss of control. That is, the…
Drug Courts
A recent research done in 1999 by College on Problems of Drug Dependence reported that, drug courts are continually providing a highly recommendable and effective control over substance-abusing offenders criminology and substance use, through court jurisdiction (p.1118). This research reported that, the rate of recidivism raged between 4% -29% for the graduates from drug court program, as compared…
Drug Screening
It directs that Federal grantees and Federal service providers shall, following forbidden strategy, look forward to set up a drug-free workplace. (Randall G. Kesselring & Jeffrey R. Pittman).…
Analytical and Synthetic Cubism
Cubism was founded by Pablo Picasso and Georges Braque, inspired by the …
Drug Dilemmas
Unfortunately, in a free market economy such as the United States, nothing can be done about it, except by government intervention through price regulation. Considering what Marcia Angell, former editor of the New England Journal of Medicine, said about how pharmaceutical companies spend enormous resources in developing "me-too" drugs simply to get a share of the market of a top-selling drug,…